These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 14595670

  • 1. Intracellular cargo delivery using tat peptide and derivatives.
    Zhao M, Weissleder R.
    Med Res Rev; 2004 Jan; 24(1):1-12. PubMed ID: 14595670
    [Abstract] [Full Text] [Related]

  • 2. Intracellular transduction using cell-penetrating peptides.
    Sawant R, Torchilin V.
    Mol Biosyst; 2010 Apr; 6(4):628-40. PubMed ID: 20237640
    [Abstract] [Full Text] [Related]

  • 3. Membrane permeability commonly shared among arginine-rich peptides.
    Futaki S, Goto S, Sugiura Y.
    J Mol Recognit; 2003 Apr; 16(5):260-4. PubMed ID: 14523938
    [Abstract] [Full Text] [Related]

  • 4. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer.
    Wadia JS, Dowdy SF.
    Adv Drug Deliv Rev; 2005 Feb 28; 57(4):579-96. PubMed ID: 15722165
    [Abstract] [Full Text] [Related]

  • 5. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
    Ziegler A, Nervi P, Dürrenberger M, Seelig J.
    Biochemistry; 2005 Jan 11; 44(1):138-48. PubMed ID: 15628854
    [Abstract] [Full Text] [Related]

  • 6. Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms.
    Futaki S.
    Biopolymers; 2006 Jan 11; 84(3):241-9. PubMed ID: 16333858
    [Abstract] [Full Text] [Related]

  • 7. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.
    Gupta B, Levchenko TS, Torchilin VP.
    Adv Drug Deliv Rev; 2005 Feb 28; 57(4):637-51. PubMed ID: 15722168
    [Abstract] [Full Text] [Related]

  • 8. Transport molecules using reverse sequence HIV-Tat polypeptides: not just any old Tat? (WO200808225).
    Howl J, Jones S.
    Expert Opin Ther Pat; 2009 Sep 28; 19(9):1329-33. PubMed ID: 19555160
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of HIV-Tat protein transduction domain.
    Yoon JS, Jung YT, Hong SK, Kim SH, Shin MC, Lee DG, Shin WS, Min WS, Paik SY.
    J Microbiol; 2004 Dec 28; 42(4):328-35. PubMed ID: 15650690
    [Abstract] [Full Text] [Related]

  • 10. Organelle-targeted delivery of biological macromolecules using the protein transduction domain: potential applications for Peptide aptamer delivery into the nucleus.
    Yoshikawa T, Sugita T, Mukai Y, Yamanada N, Nagano K, Nabeshi H, Yoshioka Y, Nakagawa S, Abe Y, Kamada H, Tsunoda S, Tsutsumi Y.
    J Mol Biol; 2008 Jul 25; 380(5):777-82. PubMed ID: 18571668
    [Abstract] [Full Text] [Related]

  • 11. A peptide carrier for the delivery of biologically active proteins into mammalian cells.
    Morris MC, Depollier J, Mery J, Heitz F, Divita G.
    Nat Biotechnol; 2001 Dec 25; 19(12):1173-6. PubMed ID: 11731788
    [Abstract] [Full Text] [Related]

  • 12. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells.
    Albarran B, To R, Stayton PS.
    Protein Eng Des Sel; 2005 Mar 25; 18(3):147-52. PubMed ID: 15820981
    [Abstract] [Full Text] [Related]

  • 13. Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide.
    Sugita T, Yoshikawa T, Mukai Y, Yamanada N, Imai S, Nagano K, Yoshida Y, Shibata H, Yoshioka Y, Nakagawa S, Kamada H, Tsunoda S, Tsutsumi Y.
    Biochem Biophys Res Commun; 2007 Nov 30; 363(4):1027-32. PubMed ID: 17923117
    [Abstract] [Full Text] [Related]

  • 14. Arginine-rich cell-penetrating peptides.
    Schmidt N, Mishra A, Lai GH, Wong GC.
    FEBS Lett; 2010 May 03; 584(9):1806-13. PubMed ID: 19925791
    [Abstract] [Full Text] [Related]

  • 15. The augmentation of intracellular delivery of peptide therapeutics by artificial protein transduction domains.
    Yoshikawa T, Sugita T, Mukai Y, Abe Y, Nakagawa S, Kamada H, Tsunoda S, Tsutsumi Y.
    Biomaterials; 2009 Jul 03; 30(19):3318-23. PubMed ID: 19304319
    [Abstract] [Full Text] [Related]

  • 16. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5.
    Goda N, Tenno T, Inomata K, Shirakawa M, Tanaka T, Hiroaki H.
    Exp Cell Res; 2008 Aug 01; 314(13):2352-61. PubMed ID: 18602100
    [Abstract] [Full Text] [Related]

  • 17. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
    Subrizi A, Tuominen E, Bunker A, Róg T, Antopolsky M, Urtti A.
    J Control Release; 2012 Mar 10; 158(2):277-85. PubMed ID: 22100438
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.